Compared to the asymptomatic carriers, the CYP17(-34)C/C genotype showed a higher expression in hepatocellular carcinoma (HCC) patients (22.5 vs. 11.2%, p = 0.05). The gene discussed is CYP17A1; the disease is hepatocellular carcinoma.